Parallel synthesis of 7-heteroaryl-pyrazolo[1,5-a]pyrimidine-3-carboxamides

Molecular Diversity

Volumn 17, Issue 4, 2013, Pages 731-743

  Ahmetaj, Sizana ^a   Velikanje, Nina ^a   Grošelj, Uroš ^a   Šterbal, Ines ^a   Prek, Benjamin ^a   Golobič, Amalija ^a   Kočar, Drago ^a   Dahmann, Georg ^b   Stanovnik, Branko ^a   Svete, Jurij ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Cyclisation; Enamino ketones; Parallel synthesis; Pyrazines; Pyrazolo 15 a pyrimidines; Pyridines

Indexed keywords

2 ACETYLPYRIDINE; 3 (DIMETHYLAMINO) 1 (HETEROARYL)PROP 2 EN 1 ONE; 5 AMINO 1H PYRAZOLE 4 CARBOXYLATE; 7 HETEROARYL PYRAZOLO [1,5 ALPHA]PYRIMIDINE 3 CARBOXAMIDE; ACETYLPYRAZINE; ALIPHATIC AMINE; AMIDE; CARBOXYLIC ACID; ESTER; N,N DIMETHYLFORMAMIDE; PYRAZINE DERIVATIVE; PYRIMIDINE DERIVATIVE; UNCLASSIFIED DRUG;

AMIDATION; ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; CYCLIZATION; HYDROLYSIS; PRIORITY JOURNAL; SYNTHESIS;

COMBINATORIAL CHEMISTRY TECHNIQUES; CYCLIZATION; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PYRAZOLES; PYRIMIDINES;

EID: 84886100484     PISSN: 13811991     EISSN: 1573501X     Source Type: Journal    
DOI: 10.1007/s11030-013-9469-3     Document Type: Article

References (32)

1. Dolle RE (2002) Solid-phase synthesis of heterocyclic systems (heterocycles containing one heteroatom). In: Nicolaou KC, Hanko R, Hartwig W (eds) Handbook of combinatorial chemistry. Drugs, catalysts, materials, vol 2. Wiley-VCH Verlag GmbH, Weinheim, pp 643-684
2. Pernerstorfer J. (2002) Molecular design and combinatorial compound libraries. In: Nicolaou KC, Hanko R, Hartwig W (eds) Handbook of combinatorial chemistry. Drugs, catalysts, materials, vol 2. Wiley-VCH Verlag GmbH, Weinheim, pp 725-742
3. Dolle RE, Le Bourdonnec B, Worm K, Morales GA, Thomas CJ, Zhang W (2010) Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009. J Comb Chem 12:765-806. doi: 10.1021/cc100128w
4. Patrick GL (2009) An introduction to medicinal chemistry, 4th edn. Oxford University Press, Oxford
5. Regan AC (2008) Pyrazolo[1,5-c ]pyrimidine (73). In: Katritzky AR, Ramsden CA, Scriven EFV, Taylor RJK (eds) Comprehensive heterocyclic chemistry III, vol 11, Cossy J. (ed), Elsevier Science Ltd., Oxford, 577; and references cited therin
6. Elnagdi MH, Elmoghayar MRH, Elgemeie GEH (1987) Chemistry of pyrazolopyrimidines. Adv Heterocycl Chem 41:319-376. doi: 10.1016/S0065-2725(08) 60164-6
7. Hwang JY, Windisch MP, Jo S, Kim HC, Kim S, Kim H, Lee ME, Park D-S, Park E, Ahn S, Cechetto J, Kim J, Liuzzi M, No Z, Lee J (2012) Discovery and characterization of a novel 7-aminopyrazolo[1,5-a ]pyrimidine analog as a potent hepatitis C virus inhibitor. Bioorg Med Chem Lett 22:7297-7301. doi: 10.1016/j.bmcl.2012.10.123
8. Ivashchenko AV, Golovina ES, Kadieva MG, Kysil VM, Mitkin OD, Okun IM (2012) Antagonists of serotonin 5-HT6 receptors. III. Pyridine-substituted 3-(phenylsulfonyl)pyrazolo[1,5-a ]pyrimidines: synthesis and structure-activity relationship. Pharm Chem J 46:406-410. doi: 10.1007/s11094-012-0810-4
9. Hanan EJ, van Abbema A, Barrett K, Blair WS, Blaney J, Chang C, Eigenbrot C, Flynn S, Gibbons P, Hurley CA, Kenny JR, Kulagowski J, Lee L, Magnuson SR, Morris C, Murray J, Pastor RM, Rawson T, Siu M, Ultsch M, Zhou A, Sampath D, Lyssikatos JP (2012) Discovery of potent and selective pyrazolopyrimidine janus kinase 2 inhibitors. J Med Chem 55:10090-10107. doi: 10.1021/jm3012239
10. Asano T, Yamazaki H, Kasahara C, Kubota H, Kontani T, Harayama Y, Ohno K, Mizuhara H, Yokomoto M, Misumi K, Kinoshita T, Ohta M, Takeuchi M (2012) Identification, synthesis, and biological evaluation of 6-[(6R)-2-(4- fluorophenyl)-6-(hydroxymethyl)-4,5,6,7-tetrahydropyrazolo[1,5-a ]pyrimidin-3-yl]-2-(2-methylphenyl)pyridazin-3(2 H) -one (AS1940477), a potent p38 MAP kinase inhibitor. J Med Chem 55:7772-7785. doi: 10.1021/jm3008008
11. Kosugi T, Mitchell DR, Fujino A, Imai M, Kambe M, Kobayashi S, Makino H, Matsueda Y, Oue Y, Komatsu K, Imaizumi K, Sakai Y, Sugiura S, Takenouchi O, Unoki G, Yamakoshi Y, Cunliffe V, Frearson J, Gordon R, Harris CJ, Kalloo-Hosein H, Le J, Patel G, Simpson DJ, Sherborne B, Thomas PS, Suzuki N, Takimoto-Kamimura M (2012) Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a ]pyrimidine inhibitors using a focused library and structure-based optimization approach. J Med Chem 55:6700-6715. doi: 10.1021/jm300411k
12. Xu J, Liu H, Li G, He Y, Ding R, Wang X, Feng M, Zhang S, Chen Y, Li S, Zhao M, Li Y, Qi C (2012) Synthesis and biological evaluation of 7-(2-chlorophenylamino)-5-((2-[18 F]fluoro-ethoxy)methyl)pyrazolo[1,5-a ]pyrimidine-3-carbonitrile as PET tumor imaging agent. Z Naturforsch 67B:827-834. doi: 10.5560/ZNB.2012-0047
13. Lopez LC, Dos-Reis S, Espargaro A, Carrodeguas JA, Maddelein M-L, Ventura S, Sancho J (2012) Discovery of novel inhibitors of amyloid β -peptide 1-42 aggregation. J Med Chem 55:9521-9530. doi: 10.1021/jm301186p
14. Hajos G, Riedl Z (2006) Aza analogues of pyrazolo[1,5-a ]pyridines containing additional nitrogen atoms in the six-membered ring. In: Neier R (ed) Science of synthesis, Houben-Weyl: methods of molecular transformations, vol 12. Thieme, Stuttgart, pp 667-678
15. Bruni F, Selleri S, Costanzo A, Guerrini G, Casilli ML, Giusti L (1995) Reactivity of 7-(2-dimethylaminovinyl)pyrazolo[1,5-a ]pyrimidines: synthesis of pyrazolo[1,5-a ]pyrido[3,4- e ]pyrimidine derivatives as potential benzodiazepine receptor ligands. 2. J Heterocycl Chem 32:291-298. doi: 10.1002/jhet.5570320149
16. Gregg BT, Tymoshenko DO, Razzano DA, Johnson MR (2007) Pyrazolo[1,5-a ]pyrimidines. Identification of the privileged structure and combinatorial synthesis of 3-(hetero)arylpyrazolo[1,5-a ]pyrimidine-6-carboxamides. J Comb Chem 9:507-512. doi: 10.1021/cc0700039
17. Japelj B, Rečnik S, Čebašek P, Stanovnik B, Svete J (2005) Synthesis and antimycobacterial activity of alkyl 1-heteroaryl-1 H -1,2,3-triazole-4-carboxylates. J Heterocycl Chem 42:1167-1173. doi: 10.1002/jhet.5570420620
18. Čebašek P, Bevk D, Pirc S, Stanovnik B, Svete J (2006) Parallel synthesis of 3-amino-4 H -quinolizin-4-ones, fused 3-amino-4 H -pyrimidin-4-ones, and fused 3-amino-2 H -pyran-2-ones. J Comb Chem 8:95-102. doi: 10.1021/cc050073k
19. Svete J, Stanovnik B (2004) Synthesis of heterocycles from alkyl 3-(dimethylamino)propenoates and related enaminones. Chem Rev 104: 2433-2480. doi: 10.1021/cr020093y (and references cited therin)
20. Svete J (2004) Ex-chiral pool enaminones in the synthesis of functionalised heterocycles. Monatsh Chem 125: 629-647. doi: 10.1007/s00706-003-0133-y (and references cited therin)
21. Baškovč J, Dahmann, G, Golobič A, Grošelj U, Kočar D, Stanovnik B, Svete J (2012) Diversity-oriented synthesis of 1-substituted 4-aryl-6-oxo-1,6-dihydropyridine-3-carboxamides. ACS Comb Sci 14:513-519. doi: 10.1021/co3000709 (and references cited therin)
22. Perdih P, Baškovč J, Dahmann G, Grošelj U, Kočar D, Novak A, Stanovnik B, Svete J (2011) Parallel synthesis of 1-substituted 5-(5-oxopyrrolidin-3-yl)-1 H -pyrazole-4-carboxamides. Synthesis 2011(17): 2822-2832. doi: 10.1055/s-0030-1261034 (and references cited therin)
23. Ho Y-W, Yao C-T (2003) Synthesis of some new 6,8-disubstituted 7,8-dihydropyrimido[2,3:4,3]pyrazolo[1,5-a ]pyrimidines and 6,7, 8-trisubstituted pyrimido[2,3:4,3]pyrazolo[1,5-a ]pyrimidine deri- vatives. J Chin Chem Soc 50: 283-296. http://proj3.sinica.edu.tw/~chem/servxx6/files/paper- 7770-1269246873.pdf
24. Nitz TJ, Salzwedel K, Finnegan C, Wild C, Brunton S, Flanagan S, Montalbetti C, Coulter TS, Kimber M, Magaraci F, Johnston D (2008) Alpha-unsubstituted arylmethylpiperazine pyrazolo[1,5-a ]pyrimidine amide derivatives as antiretroviral agents and their preparation and use in the treatment of HIV-associated diseases. WO 2008134035. Chem Abstr 149:534234
25. Kralj D, Friedrich M, Grošelj U, Kiraly-Potpara S, Meden A, Wagger J, Dahmann G, Stanovnik B, Svete J (2009) A synthesis of 1-substituted 5-[2-(acylamino)ethyl]-1 H -pyrazole-4-carboxamides. Tetrahedron 65:7151-7162. doi: 10.1016/j.tet.2009.06.021
26. Črček B, Baškovč J, Grošelj U, Kočar D, Dahmann G, Stanovnik B, Svete J (2012) Parallel synthesis of 2-substituted 6-(5-oxo- 1-phenylpyrrolidin-3-yl)pyrimidine-5-carboxamides. Molecules 17:5363-5384. doi: 10.3390/molecules17055363
27. Harwood LM, Moody CJ (1989) 'Dry Flash' column chromatography. In: Experimental organic chemistry, principles and practice. Blackwell Science, Oxford, pp 185-188
28. Harwood LM (1985) "Dry-Column" flash chromatography. Aldrichim Acta 18: 25-25. http://www.sigmaaldrich.com/content/dam/sigma-aldrich/docs/ Aldrich/Acta/al-acta-18-01.pdf
29. Farrugia LJ (1997) ORTEP-3 for Windows - a version of ORTEP-III with a Graphical User Interface (GUI) by. J. Farrugia. J Appl Crystallogr 30:568-568. doi: 10.1107/S0021889897006638
30. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Del Rev 46:3-26. doi: 10.1016/S0169-409X(00)00129-0
31. Ghose AK, Viswandhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55-68. doi: 10.1021/cc9800071
32. Nadin A, Hattotuwagama C, Churcher I (2012) Lead-oriented synthesis: a new opportunity for synthetic chemistry. Angew Chem Int Ed 51:1114-1122. doi: 10.1002/anie.201105840